Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma

Clinical trial NCT04280822 · RECRUITING

Trial details

NCT number: NCT04280822
Sponsor: Henan Cancer Hospital
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Esophageal Cancer Surgery Neoadjuvant Treatment Survival

Start date: 2020-04-21
Primary completion: 2023-12-02
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.